StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens increased their price target on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
Check Out Our Latest Research Report on Veradigm
Veradigm Price Performance
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What is the Nasdaq? Complete Overview with History
- Inflation Persists, But So Do Stock Opportunities: Rally On
- What Are Some of the Best Large-Cap Stocks to Buy?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
